Reduced bone mineral density in hypertensive patients is associated with left ventricular diastolic dysfunction, not left ventricular hypertrophy

Clinical and Experimental Hypertension

Volumn 34, Issue 3, 2012, Pages 176-181

  Masugata, Hisashi ^a   Senda, Shoichi ^a   Murao, Koji ^a   Inukai, Michio ^a   Hosomi, Naohisa ^b   Iwado, Yasuyoshi ^a   Noma, Takahisa ^a   Kohno, Masakazu ^a   Miyatake, Nobuyuki ^c   Himoto, Takashi ^a   Goda, Fuminori ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Hypertension; Left ventricular diastolic dysfunction; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BONE DENSITY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE DIASTOLIC DYSFUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE;

AGED; AGED, 80 AND OVER; BONE DENSITY; DIASTOLE; FEMALE; HEART FAILURE; HEMOGLOBINS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84859748042     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2011.577490     Document Type: Article

References (37)

1. MartiniG, RabbiaF,GastaldiL,etal. Heart ratevariability and left ventricular diastolic function in patients with borderlinehypertensionwithand withoutleftventricularhypertrophy. Clin ExpHypertens 2001; 23(1-2):77-87. (Pubitemid 32183258)
2. Rosei EA, Muiesan ML. Early target organ damage and its reversibility: The heart. Clin Exp Hypertens 2004; 26(7-8): 673-687. (Pubitemid 40129756)
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined leftventricularmassinthe Framingham Heart Study.NEnglJ Med 1990; 322(22):1561-1566. (Pubitemid 20176696)
4. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significanceof serial changesinleftventricular massin essential hypertension.Circulation 1998; 97(1):48-54. (Pubitemid 28036154)
5. Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 2002; 39(12): 2005-2011. (Pubitemid 34628283)
6. RedfieldMM,JacobsenSJ,BurnettJCJr,etal. Burdenof systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 2003; 289(2):194-202. (Pubitemid 36068707)
7. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heartfailurein thecommunity: A studyof allincident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98(21):2282-2289.
8. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348(20):2007-2018.
9. Owan TE, Redfield MM. Epidemiology of diastolic heart failure.ProgCardiovascDis 2005; 47(5):320-332. (Pubitemid 40884561)
10. Lakatta EG. Arterial pressure and aging. Int. J. Cardiol 1989; 25(Suppl.1):S81-S89. (Pubitemid 20012848)
11. Lakatta EG. Similarmyocardial effectsof aging andhypertension. Eur HeartJ1990; 11(Suppl.G):29-38.
12. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure andbone-mineral lossin elderlywhitewomen: Aprospective study.Study of OsteoporoticFractures Research Group. Lancet 1999; 354(9183):971-975.
13. Tsuda K, Nishio I, Masuyama Y. Bone mineral density in women with essential hypertension. AmJHypertens 2001; 14(7Pt1):704-707. (Pubitemid 32612537)
14. PennisiP, Signorelli SS, RiccobeneS, et al.Low bone density andabnormalboneturnoverinpatientswithatherosclerosis of peripheralvessels. OsteoporosInt 2004; 15(5):389-395. (Pubitemid 38639334)
15. UyamaO,YoshimotoY,YamamotoY,KawaiA.Bonechanges and carotid atherosclerosis in postmenopausal women. Stroke 1997; 28(9):1730-1732. (Pubitemid 27391440)
16. Resnick LM, Laragh JH, Sealey JE, Alderman MH. Divalent cationsinessentialhypertension. Relationsbetween serumionized calcium, magnesium, andplasmarenin activity.N EnglJ Med 1983; 309(15):888-891. (Pubitemid 13014029)
17. Imaoka M, Morimoto S, Kitano S, Fukuo F, Ogihara T. Calcium metabolism in elderly hypertensive patients: Possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol 1991; 18(9): 631-641.
18. Wallerson DC, Devereux RB. Reproducibility of echocardiographic left ventricular measurements. Hypertension 1987; 9(2Pt2):II6-II18.
19. Teichholz LE, KreulenT, HermanMV, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic an giographic correlations in the presence of absence of asynergy. AmJCardiol 1976; 37(1):7-11.
20. Nishimura RA, Appleton CP. "Diastology":beyondEandA.J Am Coll Cardiol 1996; 27(2):372-374.
21. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997; 30(1): 8-18. (Pubitemid 27357121)
22. SohnDW,ChaiIH, LeeDJ, et al. Assessmentof mitralannulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30(2):474-480.
23. OmmenSR, NishimuraRA, AppletonCP,et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in theestimationof leftventricularfillingpressures:acomparative simultaneous Doppler- catheterization study.Circulation 2000; 102(15):1788-1794.
24. Guglielmi G, De Terlizzi F. Quantitative ultrasound in the assessment of osteoporosis. Eur J Radiol 2009; 71(3): 425-431.
25. Iida T, Chikamura C, Aoi S, et al. A study on the validity of quantitative ultrasonic measurement used the bone mineral density values on dual-energy X-ray absorptiometry in young and inmiddle-aged or older women. Radiol Phys Technol 2010; 3(2):113-119.
26. Abe Y, Takamura N, Ye Z, et al. Quantitative ultrasound and radiographic absorptiometry are associated with verteconverting bral deformity in Japanese Women: The Hizen-Oshima study. Osteoporos Int 2010; Jun 29. Epub ahead ofprint.
27. Mergler S, Löbker B, Evenhuis HM, Penning C. Feasibility of quantitative ultrasound measurement of the heel bone in peoblockers, with intellectual disabilities. Res Dev Disabil 2010; 31(6): 1283-1290.
28. Nordström A, Eriksson M, Stegmayr B, Gustafson Y, Nord[ström P. Low bone mineral density is an independent risk factor for stroke and death. Cerebrovasc Dis 2010; 29(2): 130-136.
29. Aeschbacher BC, Hutter D, Fuhrer J, et al. Diastolic hypertensive rats. Hypertens Res 2009; 32(9): 786-790.
30. Chang NC, Lai ZY, Wang TC. Enalapril does not improve left density in chronic peritoneal dialysis patients. Clin Nephrol 2010; 74(5):336-342.
31. Jessup JA, Westwood BM, Chappell MC, Dual GL. ACE-inhibition and AT1 receptor antagonism improves ventricular
32. Lynn H, Kwok T, Wong SY, Woo J, Leung PC. Angiotensin enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 2006; 38(4): 584-588.
33. Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-ACE inhibitors, and calcium-channel blockers is assople ciated with a reduced fracture risk: A nationwide case-control study. JHypertens 2006; 24(3):581-589. (Pubitemid 43261923)
34. Shimizu H, Nakagami H, Osako M.K., et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 2008; 22(7):2465-2475. (Pubitemid 351948664)
35. Shimizu H, Nakagami H, Osako MK et al. Prevention of dysfunction precedes myocardial hypertrophy in the develspontaneous opment of hypertension. Am. J. Hypertens 2001; 14(2): 106-113.
36. Jeong JU, Lee HK, Kim YJ, et al. Nutritional markers, not diastolic dysfunction in young and mild hyperteneral sives without concomitant hypertrophy. Am JHypertens 1996; 14(9):909-914.
37. Jesudason D, Clifton P. The interaction between dietary protein and bone health. J Bone Miner Metab 2011; 29(1): 1-14.